Literature DB >> 21892358

Comparing different scientific approaches to personalized medicine: research ethics and privacy protection.

Martin Langanke1, Kyle B Brothers, Pia Erdmann, Jakob Weinert, Janina Krafczyk-Korth, Marcus Dörr, Wolfgang Hoffmann, Heyo K Kroemer, Heinrich Assel.   

Abstract

In this article, two different scientific approaches to personalized medicine are compared. Biorepository at Vanderbilt University (BioVU) is a genomic biorepository at Vanderbilt University Medical Center in Nashville, TN, USA. Genetic biosamples are collected from leftover clinical blood samples; medical information is derived from an electronic medical records. Greifswald Approach to Individualized Medicine is a research resource at the University of Greifswald, Germany, comprised of clinical records combined with biosamples collected for research. We demonstrate that although both approaches are based on the collection of clinical data and biosamples, different legal milieus present in the USA and Germany as well as slight differences in scientific goals have led to different 'ethical designs'. While BioVU can successfully operate with an 'opt-out' mechanism, an informed consent-based 'opt-in' model is indispensable to allow GANI_MED to reach its scientific goals.

Entities:  

Year:  2011        PMID: 21892358      PMCID: PMC3164515          DOI: 10.2217/pme.11.34

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  12 in total

Review 1.  Opt in or opt out: what is optimal for prenatal screening for HIV infection?

Authors:  Sharon Walmsley
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

2.  "Human non-subjects research": privacy and compliance.

Authors:  Kyle Bertram Brothers; Ellen Wright Clayton
Journal:  Am J Bioeth       Date:  2010-09       Impact factor: 11.229

3.  Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record.

Authors:  Marylyn D Ritchie; Joshua C Denny; Dana C Crawford; Andrea H Ramirez; Justin B Weiner; Jill M Pulley; Melissa A Basford; Kristin Brown-Gentry; Jeffrey R Balser; Daniel R Masys; Jonathan L Haines; Dan M Roden
Journal:  Am J Hum Genet       Date:  2010-04-01       Impact factor: 11.025

4.  Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies.

Authors:  Cornelia Junghans; Gene Feder; Harry Hemingway; Adam Timmis; Melvyn Jones
Journal:  BMJ       Date:  2005-09-12

5.  Development of a large-scale de-identified DNA biobank to enable personalized medicine.

Authors:  D M Roden; J M Pulley; M A Basford; G R Bernard; E W Clayton; J R Balser; D R Masys
Journal:  Clin Pharmacol Ther       Date:  2008-05-21       Impact factor: 6.875

6.  Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think?

Authors:  Asa Kettis-Lindblad; Lena Ring; Eva Viberth; Mats G Hansson
Journal:  Eur J Public Health       Date:  2005-10-05       Impact factor: 3.367

7.  Principles of human subjects protections applied in an opt-out, de-identified biobank.

Authors:  Jill Pulley; Ellen Clayton; Gordon R Bernard; Dan M Roden; Daniel R Masys
Journal:  Clin Transl Sci       Date:  2010-02       Impact factor: 4.689

8.  PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations.

Authors:  Joshua C Denny; Marylyn D Ritchie; Melissa A Basford; Jill M Pulley; Lisa Bastarache; Kristin Brown-Gentry; Deede Wang; Dan R Masys; Dan M Roden; Dana C Crawford
Journal:  Bioinformatics       Date:  2010-03-24       Impact factor: 6.937

9.  Attitudes and perceptions of patients towards methods of establishing a DNA biobank.

Authors:  Jill M Pulley; Margaret M Brace; Gordon R Bernard; Dan R Masys
Journal:  Cell Tissue Bank       Date:  2007-10-25       Impact factor: 1.522

Review 10.  Managing incidental findings in human subjects research: analysis and recommendations.

Authors:  Susan M Wolf; Frances P Lawrenz; Charles A Nelson; Jeffrey P Kahn; Mildred K Cho; Ellen Wright Clayton; Joel G Fletcher; Michael K Georgieff; Dale Hammerschmidt; Kathy Hudson; Judy Illes; Vivek Kapur; Moira A Keane; Barbara A Koenig; Bonnie S Leroy; Elizabeth G McFarland; Jordan Paradise; Lisa S Parker; Sharon F Terry; Brian Van Ness; Benjamin S Wilfond
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

View more
  6 in total

1.  Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study.

Authors:  Carsten Oliver Schmidt; Katrin Hegenscheid; Pia Erdmann; Thomas Kohlmann; Martin Langanke; Henry Völzke; Ralf Puls; Heinrich Assel; Reiner Biffar; Hans Jörgen Grabe
Journal:  Eur Radiol       Date:  2012-12-13       Impact factor: 5.315

2.  Implications of the incidentalome for clinical pharmacogenomics.

Authors:  Kyle B Brothers; Martin Langanke; Pia Erdmann
Journal:  Pharmacogenomics       Date:  2013-08       Impact factor: 2.533

3.  Secondary use of clinical data: the Vanderbilt approach.

Authors:  Ioana Danciu; James D Cowan; Melissa Basford; Xiaoming Wang; Alexander Saip; Susan Osgood; Jana Shirey-Rice; Jacqueline Kirby; Paul A Harris
Journal:  J Biomed Inform       Date:  2014-02-14       Impact factor: 6.317

4.  Cohort profile: Greifswald approach to individualized medicine (GANI_MED).

Authors:  Hans J Grabe; Heinrich Assel; Thomas Bahls; Marcus Dörr; Karlhans Endlich; Nicole Endlich; Pia Erdmann; Ralf Ewert; Stephan B Felix; Beate Fiene; Tobias Fischer; Steffen Flessa; Nele Friedrich; Mariacarla Gadebusch-Bondio; Manuela Gesell Salazar; Elke Hammer; Robin Haring; Christoph Havemann; Michael Hecker; Wolfgang Hoffmann; Birte Holtfreter; Tim Kacprowski; Kathleen Klein; Thomas Kocher; Holger Kock; Janina Krafczyk; Jana Kuhn; Martin Langanke; Uwe Lendeckel; Markus M Lerch; Wolfgang Lieb; Roberto Lorbeer; Julia Mayerle; Konrad Meissner; Henriette Meyer zu Schwabedissen; Matthias Nauck; Konrad Ott; Wolfgang Rathmann; Rainer Rettig; Claudia Richardt; Karen Saljé; Ulf Schminke; Andrea Schulz; Matthias Schwab; Werner Siegmund; Sylvia Stracke; Karsten Suhre; Marius Ueffing; Saskia Ungerer; Uwe Völker; Henry Völzke; Henri Wallaschofski; Vivian Werner; Marek T Zygmunt; Heyo K Kroemer
Journal:  J Transl Med       Date:  2014-05-23       Impact factor: 5.531

5.  Implementation of Electronic Consent at a Biobank: An Opportunity for Precision Medicine Research.

Authors:  Natalie T Boutin; Kathleen Mathieu; Alison G Hoffnagle; Nicole L Allen; Victor M Castro; Megan Morash; P Pearl O'Rourke; Elizabeth L Hohmann; Neil Herring; Lynn Bry; Susan A Slaugenhaupt; Elizabeth W Karlson; Scott T Weiss; Jordan W Smoller
Journal:  J Pers Med       Date:  2016-06-09

6.  Applying systems biology to biomedical research and health care: a précising definition of systems medicine.

Authors:  Sebastian Schleidgen; Sandra Fernau; Henrike Fleischer; Christoph Schickhardt; Ann-Kristin Oßa; Eva C Winkler
Journal:  BMC Health Serv Res       Date:  2017-11-21       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.